Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30 Apr 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1.93B | 1.85B | 1.76B | 1.63B | 1.57B | 1.51B |
| Cost of revenue | 175M | 165M | 159M | 160M | 147M | 140M |
| Gross profit | 1.76B | 1.69B | 1.60B | 1.47B | 1.42B | 1.37B |
| Research and development | 421M | 416M | 413M | 394M | 378M | 368M |
| Selling, general and administrative | 162M | 172M | 168M | 162M | 161M | 161M |
| Operating expenses | 1.22B | 1.22B | 1.16B | 1.24B | 1.08B | 1.02B |
| Operating income | 541M | 470M | 444M | 233M | 346M | 343M |
| Pre-tax income | 599M | 468M | 456M | 234M | 351M | 352M |
| Income tax | 108M | 125M | 143M | 82M | 76M | 70M |
| Net income | 491M | 343M | 313M | 152M | 275M | 282M |
| Earnings per share | 2.33 | 1.61 | 1.47 | 0.71 | 1.28 | 1.31 |
| Earnings per share, diluted | 2.32 | 1.60 | 1.46 | 0.70 | 1.27 | 1.30 |
| Weighted average shares | 211M | 213M | 213M | 214M | 215M | 216M |
| Weighted average shares, diluted | 212M | 215M | 215M | 216M | 217M | 217M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.67B | 2.25B | 1.99B | 2.00B | 1.82B | 1.60B | 1.44B | 1.51B |
| Short-term investments | 253M | 348M |
| Metric | 30 Apr 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 893M | — | — | 564M | — | — |
| Depreciation and amortisation | 51M | 50M | 47M | 48M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 300M |
| 233M |
| 224M |
| 287M |
| 276M |
| 365M |
| Receivables | 579M | 1.44B | 806M | 532M | 494M | 1.01B | 702M | 402M |
| Current assets | 4.37B | 4.94B | 3.90B | 3.49B | 3.22B | 3.48B | 2.90B | 2.76B |
| Property, plant and equipment | 122M | 121M | 118M | 109M | 111M | 117M | 116M | 116M |
| Goodwill | 4.34B | 4.30B | 4.28B | 4.28B | 4.28B | 4.24B | 4.26B | 4.25B |
| Total assets | 11.93B | 12.47B | 11.20B | 10.86B | 10.59B | 10.83B | 10.13B | 9.96B |
| Current liabilities | 5.24B | 5.81B | 4.74B | 4.57B | 4.92B | 5.15B | 4.47B | 4.34B |
| Equity | 3.19B | 3.05B | 2.89B | 2.72B | 2.62B | 2.62B | 2.62B | 2.47B |
| Shares outstanding | — | 212M | — | — | — | 214M | — | — |
| Shares issued | — | 212M | — | — | — | 214M | — | — |
| 48M |
| 46M |
| Share-based compensation | 155M | — | — | 230M | — | — |
| Capital expenditure | 17M | — | — | 8M | — | — |
| Investing cash flow | 29M | — | — | 58M | — | — |
| Share buybacks | 448M | — | — | 354M | — | — |
| Financing cash flow | −498M | — | — | −415M | — | — |